2026 Jinan Drug Pollution Control Strategy (CCS) Summit

The 2026 CCS (Contamination Control Strategy) Summit for Pharmaceuticals was successfully held in Jinan on July 23-24, 2026. This conference focused on sterile appendix, contamination control practices, and global pharmaceutical regulations. Over a hundred experts from drug regulatory authorities, industry tech leaders, and pharmaceutical production quality heads gathered to the conference, including the 'Cleanroom Validation Technical Guide,' PDA TR22 'Sterile Process Simulation' guide, and PDA TR26 'Liquid Sterile Filtration' guide, exploring new ways to implement contamination control in the pharmaceutical industry.

HanKing showcased multiple core products designed specifically to meet pharmaceutical compliance needs which attracted a lot of attention from many pharma professionals and becoming a popular interactive area during the forum.

Four products we’re bringing this time match the conference’s focus on pollution control and compliance upgrades:

✅ ‌ABC Transfer^® Ultra-clean sterile transfer solution: Specially designed to address the risk of cross-contamination during material transfer in Grade A environments, with fully enclosed operations and no exposed handling, perfectly meeting the strict requirements for sterile transport in the new sterile appendix.

✅ ‌Sterile film evaporator: Helps pharmaceutical companies achieve fully closed sterile control during the concentration of heat-sensitive materials, reducing the chances of microbial and particle contamination in the evaporation process.

✅ ‌BUCHI Sepiatec: Supercritical fluid chromatography system (SFC): Designed to provide efficient separation and purification solutions for chiral compounds in the pharmaceutical industry, greatly reducing the risk of contamination during the purification process, while also accommodating the closed handling needs of highly active products.

✅ ‌Liquid chromatography accessories and consumables: We offer a full range of compliant, high-quality consumables to ensure reliable data in pharmaceutical labs and maintain a stable, sterile, controlled environment.

Q &A from Visitors

We received product inquiries from many industry partners and have compiled and replied to the frequently asked questions.

ABC Transfer^® Ultra-clean Aseptic transfer solutions

Is this transfer plan meet the material transfer needs at different levels in a multi-product co-production scenario, as well as the subsequent cleaning validation compliance audits?

ABC Transfer^® Ultra-clean aseptic transfer solution supports cross-level material transport adaptation from grade A to grade C cleanrooms, with fully enclosed, no-exposure operations, effectively eliminating the risk of cross-contamination between different products.

How compatible is this solution? WIll it be directly connected after the modification on our existing transfer equipment?

This solution supports customized interface adaptation and can match the material transfer ports of almost all mainstream sterile process equipment, isolators, and freeze dryers on the market. It can be implemented without major modifications to existing production lines, significantly reducing the cost of upgrades for companies.

Sterile film evaporator

Is this sterile film evaporator prevent material leaks and cross-contamination when handling highly active and highly sensitizing substances?

The film evaporator uses a fully enclosed negative pressure loop design, with no exposed materials at all. It can completely prevent highly active powder aerosols from spreading out, keeping operators safe, and also fully blocks external particles and microbes from entering the material system. It fully meets the safety and contamination control requirements for handling highly active products discussed at this conference.

Is it hard to confirm the device is clean? Can it meet the ongoing cleaning verification requirements of the new version?

The internal flow channels of the equipment are designed with full polishing and no dead corners, so there are almost no cleaning blind spots. It can provide a complete set of cleaning validation guidance, easily meeting the compliance requirements for ongoing cleaning verification in the 2025 version of the 'Guideline for Pharmaceutical Cleaning Validation'.

BUCHI Sepiate Supercritical Fluid Chromatography System（SFC）

Compared to traditional liquid-phase purification methods, what advantages does this SFC system have in terms of contamination control?

Traditional liquid-phase purification requires a lot of shipping reagents, and managing pollution during reagent recovery and disposal is tough. But SFC uses CO2 as the main mobile phase, cutting organic solvent use by over 90%. This not only greatly reduces the chance of introducing external contamination from solvents but also simplifies the later solvent residue verification process, helping companies ease compliance pressure.

During the live interaction session, many lab tech leads from pharmaceutical companies showed interest in the liquid-phase related equipment we were showcasing. They requested a trial of the solvent-sealed filtration system, hoping to test its airtight and contamination-proof capabilities firsthand in their own production lines or lab settings.

HanKing has also received follow-up cooperation intentions from many industry partners. In the future, we will continue to stay up-to-date with the latest pharmaceutical compliance regulations at home and abroad, offering technical solutions that better address the real pollution control challenges faced by pharmaceutical companies.

If you have any questions about product details, need a customized plan, product trial or get brochures, Please leave a message.

Keywords:

FILTRIX™ sterile film evaporation system, the 'exclusive key' for peptide commercialization!

Analysis method of Copper Tripeptide-1 according to 'YY/T 10005-2026 Raw Materials for Cosmetics - Copper Tripeptide-1'